Skip to main content

Table 1 Patient’s characteristics

From: The prognostic role of PD-1, PD-L1, ALK, and ROS1 proteins expression in non-small cell lung carcinoma patients from Egypt

Characteristics

 

Age (years), mean ± SD

55.2 ± 9.8

Age, N (%)

 < 55

32 (45.7)

 ≥ 55

38 (54.3)

Gender, N (%)

 Female

19 (27.1)

 Male

51 (72.9)

Smoking status, N (%)

 Never-smoker

27 (38.6)

 Current/ex-smoker

43 (61.4)

Grade, N (%)

 1–2

51 (72.9)

 3

19 (27.1)

Stage, N (%)

 I

12 (17.1)

 II

15 (21.4)

 III

12 (17.1)

 IV

31 (44.3)

Tumor size (cm), mean ± SD

5.4 ± 2.78

Tumor size (cm), N (%)

 < 4

25 (35.7)

 ≥ 4

45 (64.3)

Laterality, N (%)

 Left

36 (51.4)

 Right

34 (48.6)

LN metastasis, N (%)

 No

34 (48.6)

 Yes

36 (51.4)

EGFR mutation, N (%)

 Wild type

40 (57.1)

 Mutant

21 (30.0)

 Unknown

9 (12.9)

  1. LN lymph node, EGFR epidermal growth factor receptor